drugset / Trial / NCT06344065
Immunogenicity and Safety of Diphtheria, Tetanus, Pertussis (DTaP) Vaccine in 3-month-old Infants
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to evaluate the safety and immunogenicity of the DTaP in 3-month-old infants.
Timeline
- Start
- 2023-12-21
- Primary completion
- 2025-05-25
- Completion
- 2028-12-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Diphtheria, tetanus and acellular pertussis (component) combined vaccine (adsorbed) | Vaccine | 0.5 ml | Intramuscular |
| Comparator | Diphtheria, tetanus and acellular pertussis combined vaccine (adsorbed) | Vaccine | 0.5 ml | Intramuscular |
| Comparator | Diphtheria, tetanus, pertussis (acellular, component), poliomyelitis (inactivated) vaccine (adsorbed) and Haemophilus influenzae type b conjugate vaccine | Vaccine | 0.5 ml | Intramuscular |
Indications
No indication recorded.